GEN is a leading magazine and news publication focused on genetic engineering and biotechnology, providing news, analysis, features, webinars, podcasts, and industry insights. It covers topics such as genome editing, bioprocessing, cancer, drug discovery, and translational medicine, with a global reach through Sage Publications. The publication aggregates expert commentary, research trends, and industry news to inform scientists, researchers, and biotechnology professionals. Based in the United States and operating as a scientific media brand, GEN serves researchers, clinicians, and industry stakeholders worldwide.
No recent deals for this company.